Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:RCEL 29 December 2025

Regencell stock slips in premarket after Friday’s 14% drop puts focus back on volatility

Regencell stock slips in premarket after Friday’s 14% drop puts focus back on volatility

Regencell Bioscience shares fell 3.2% to $20.48 in premarket trading Monday, after dropping nearly 14% in the prior session. The company last issued news in October, reporting no product sales, ongoing losses, and a “going concern” warning in its annual filing. Regencell has not applied for regulatory approvals and depends on raising more capital to continue operating.
29 December 2025
·

Stock Market Today

  • WEX Inc. Shares Rise 3.43% on Strategic Partnerships and Strong Q4 Performance
    March 20, 2026, 5:32 PM EDT. WEX Inc. stock surged 3.43% amid renewed investor confidence driven by strategic partnership announcements and robust Q4 2025 results. The company posted an EBIT margin of 20.2% and EBITDA margin of 33%, highlighting solid operational efficiency and profitability. Despite a dip to $148.90, shares rebounded to $156.89. WEX's strong cash position of $1.68 billion and significant debt reduction of over $10.56 billion demonstrate financial stability. Analysts note the company's reasonable valuation, with a price-to-earnings ratio of 17.52 and manageable debt servicing ability. Technical indicators point to a support level near $150, suggesting potential upside if sector momentum continues. WEX's steady revenue growth and above-average returns reinforce its competitive stance in the finance sector.
Go toTop